(NASDAQ:POAI) PREDICTIVE ONCOLOGY is trading more than 40% down today on news of the closing of an offering.
Predictive Oncology Announces $7.2 Million Registered Direct Offerings
EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (Nasdaq: POAI) (Predictive Oncology or the Company), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional investors for the issuance and sale of shares of its common stock, with related agreements regarding certain stock purchase warrants, in connection with two concurrent offerings that are expected to result in gross proceeds totaling approximately $7.2 million before deducting placement agent fees and other offerings expenses.
Read the entire article here: https://www.globenewswire.com/news-release/2021/02/11/2173688/0/en/Predictive-Oncology-Announces-7-4-Million-Registered-Direct-Offering-Priced-At-The-Market-under-Nasdaq-Rules.html
